Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In the phase 2 dose-finding trial involving 706 participants, nausea rates varied dramatically by dose
Laboratory findings in the form of low hemoglobin or hematocrit should be recorded in clinical documentation
BPC-157s demonstrated ability to heal intestinal mucosal damage and protect against various forms of GI insult provides targeted support during this challenging phase
By submitting your photo, you agree that the patient in the photo is not identifiable or has signed a waiver in compliance with HIPAA regulations
US$ 24.02
US$ 22.81
US$ 21.56
US$ 20.87
US$ 26.15
US$ 21.97
US$ 27.09
US$ 29.86
US$ 22.68
US$ 23.64
